Liu Shuhua, Xu Liping, Cheng Yan, Liu Dehong, Zhang Bin, Chen Xianxia, Zheng Mingming
Department of Obstetrics and Gynecology, Hefei Maternal and Child Health Hospital, Hefei, China.
Department of Obstetrics and Gynecology, Anhui Women and Children's Medical Center, Hefei, China.
Front Endocrinol (Lausanne). 2025 Mar 11;16:1502329. doi: 10.3389/fendo.2025.1502329. eCollection 2025.
This study speculates that gestational diabetes mellitus (GDM) may reduce fetal telomere length (TL),which may be related to modification of methylation in the promoter region of the telomerase (TE) gene promoter region.
In this study, umbilical cord blood samples from patients with and without GDM (N = 100 each) were analyzed by prospective case-control. The TL, TE expression levels, and methylation levels of TERT and TERC gene promoter regions in two groups were measured. The significance of the methylation level of each CpG locus employed logistic regression analysis of R software, and the analysis of covariance (ANCOVA) was used to control the influence of confounding factors. Correlation analysis was performed by the Spearman.
The TL and TE expression levels of the offspring of GDM patients were decreased despite adjusting for PBMI, PWG, and TG. A total of two CpG islands were screened in the promoter region of the TERT gene and three fragments (TERT_2, TERT_3, and TERT_4) containing a total of 70 CpG sites were designed. Additionally, four CpG sites of the TERT gene in the GDM group (TERT_2_40, TERT_2_47, TERT_3_46, and TERT_3_212) showed increased methylation levels compared with the control group (all P < 0.05). In the promoter region of the TERC gene, one CpG island containing 19 CpG loci was screened and designed, and the methylation levels of the two CpG sites were significantly different in TERC_1_67 (0.65 ± 0.21 versus 0.57 ± 0.30; P = 0.040) and TERC_1_120 (0.68 ± 0.23 versus 0.59 ± 0.27; P = 0.014). The methylation levels of TERC gene fragments of GDM patients were significantly higher than those of the control group (0.69 ± 0.06 versus 0.65 ± 0.08, P = 0.001).
This study revealed that GDM may induce decreased TE expression by increasing the methylation levels of TE genes promoter region, thereby reducing the TL.
本研究推测妊娠期糖尿病(GDM)可能会缩短胎儿端粒长度(TL),这可能与端粒酶(TE)基因启动子区域甲基化修饰有关。
本研究采用前瞻性病例对照研究方法,分析了100例GDM患者和100例非GDM患者的脐带血样本。检测了两组中端粒长度、端粒酶表达水平以及TERT和TERC基因启动子区域的甲基化水平。采用R软件的逻辑回归分析每个CpG位点甲基化水平的显著性,并使用协方差分析(ANCOVA)控制混杂因素的影响。采用Spearman进行相关性分析。
尽管对孕前体重指数(PBMI)、孕期体重增加(PWG)和甘油三酯(TG)进行了校正,但GDM患者后代的端粒长度和端粒酶表达水平仍降低。在TERT基因启动子区域共筛选出两个CpG岛,并设计了包含70个CpG位点的三个片段(TERT_2、TERT_3和TERT_4)。此外,与对照组相比,GDM组TERT基因的四个CpG位点(TERT_2_40、TERT_2_47、TERT_3_46和TERT_3_212)甲基化水平升高(均P<0.05)。在TERC基因启动子区域,筛选并设计了一个包含19个CpG位点的CpG岛,TERC_1_67(0.65±0.21对0.57±0.30;P=0.040)和TERC_1_120(0.68±0.23对0.59±0.27;P=0.014)两个CpG位点的甲基化水平差异有统计学意义。GDM患者TERC基因片段的甲基化水平显著高于对照组(0.69±0.06对0.65±0.08,P=0.001)。
本研究表明,GDM可能通过增加TE基因启动子区域的甲基化水平诱导端粒酶表达降低,从而缩短端粒长度。